.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Cipla
UBS
Accenture
McKesson
US Army
AstraZeneca
Johnson and Johnson
Argus Health
Queensland Health

Generated: February 19, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Germany Patent: 102 38 243

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Boehringer IngelheimJENTADUETO XRlinagliptin; metformin hydrochlorideTABLET, EXTENDED RELEASE;ORAL208026-001May 27, 2016RXYesNo➤ Sign Up➤ Sign UpYY
Boehringer IngelheimJENTADUETO XRlinagliptin; metformin hydrochlorideTABLET, EXTENDED RELEASE;ORAL208026-002May 27, 2016RXYesYes➤ Sign Up➤ Sign UpYY
Boehringer IngelheimGLYXAMBIempagliflozin; linagliptinTABLET;ORAL206073-001Jan 30, 2015RXYesNo➤ Sign Up➤ Sign UpYY
Boehringer IngelheimGLYXAMBIempagliflozin; linagliptinTABLET;ORAL206073-002Jan 30, 2015RXYesYes➤ Sign Up➤ Sign UpYY
Boehringer IngelheimJENTADUETOlinagliptin; metformin hydrochlorideTABLET;ORAL201281-003Jan 30, 2012RXYesYes➤ Sign Up➤ Sign UpYY
Boehringer IngelheimJENTADUETOlinagliptin; metformin hydrochlorideTABLET;ORAL201281-001Jan 30, 2012RXYesNo➤ Sign Up➤ Sign UpYY
Boehringer IngelheimJENTADUETOlinagliptin; metformin hydrochlorideTABLET;ORAL201281-002Jan 30, 2012RXYesNo➤ Sign Up➤ Sign UpYY
Boehringer IngelheimTRADJENTAlinagliptinTABLET;ORAL201280-001May 2, 2011RXYesYes➤ Sign Up➤ Sign UpYY
Boehringer IngelheimJENTADUETO XRlinagliptin; metformin hydrochlorideTABLET, EXTENDED RELEASE;ORAL208026-001May 27, 2016RXYesNo➤ Sign Up➤ Sign UpMETHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASE-IV INHIBITOR
Boehringer IngelheimJENTADUETO XRlinagliptin; metformin hydrochlorideTABLET, EXTENDED RELEASE;ORAL208026-002May 27, 2016RXYesYes➤ Sign Up➤ Sign UpMETHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASE-IV INHIBITOR
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist